ADMA Biologics’ year-to-date stock performance.
ADMA Biologics: “This is a very speculative situation…Any time there’s immunity compromised patients, there’s some big money down the road.”
MP Materials’ year-to-date stock performance.
MP Materials: “This is one of those situations that is very difficult…If they don’t pull out of the tailspin of losses, then it just doesn’t matter.”
Delcath Systems’ year-to-date stock performance.
Delcath Systems: “There’s no investing. At this point, it is speculating.”
Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.
Questions for Cramer?
Call Cramer: 1-800-743-CNBC
Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money Twitter – Jim Cramer Twitter – Facebook – Instagram
Questions, comments, suggestions for the “Mad Money” website? [email protected]